Asia Pacific Colorectal Cancer Diagnostics Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
USD 530,001.39 Thousand |
 Taille du marché (année de prévision) |
USD 1,056,573.99 Thousand |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché du diagnostic du cancer colorectal en Asie-Pacifique, par type de test (examen des selles, test d'imagerie, biopsie, test sanguin et autres), type de produit (instruments, kits et réactifs), stades du cancer (stade 0, stade I, stade II, stade III et stade IV), type de cancer (adénocarcinome, lymphome colorectal, tumeurs stromales gastro-intestinales , tumeurs carcinoïdes, léiomyosarcomes, mélanomes et autres), groupe d'âge (gériatrique, adultes et pédiatrique), utilisateur final (hôpital, centres de diagnostic, centres de recherche sur le cancer, centres de chirurgie ambulatoire, instituts universitaires et autres), canal de distribution (appel d'offres direct, ventes au détail et ventes en ligne) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché du diagnostic du cancer colorectal en Asie-Pacifique
La sensibilisation croissante de la région Asie-Pacifique au cancer colorectal a renforcé la demande du marché. L'augmentation des dépenses de santé pour de meilleurs services de santé contribue également à la croissance du marché. Les principaux acteurs du marché se concentrent sur le lancement et l'approbation de divers services au cours de cette période cruciale. En outre, l'augmentation des processus et techniques de diagnostic améliorés contribue également à la demande croissante de tests de diagnostic du cancer colorectal.
Le marché du diagnostic du cancer colorectal en Asie-Pacifique devrait croître au cours de la période de prévision de 2023 à 2030. Data Bridge Market Research analyse que le marché croît avec un TCAC de 9,0 % au cours de la période de prévision de 2023 à 2030 et devrait atteindre 1 056 573,99 milliers USD d'ici 2030 contre 530 001,39 milliers USD en 2022.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable de 2015 à 2020) |
|
Unités quantitatives |
Chiffre d'affaires en milliers de dollars américains |
|
Segments couverts |
Type de test (examen des selles, test d'imagerie, biopsie, analyse sanguine et autres), type de produit (instruments, kits et réactifs), stades du cancer (stade 0, stade I, stade II, stade III et stade IV), type de cancer (adénocarcinome, lymphome colorectal, tumeurs stromales gastro-intestinales, tumeurs carcinoïdes, léiomyosarcomes, mélanomes et autres), groupe d'âge (gériatrie, adultes et pédiatrie), utilisateur final (hôpital, centres de diagnostic, centres de recherche sur le cancer, centres de chirurgie ambulatoire, instituts universitaires et autres), canal de distribution (appel d'offres direct, vente au détail et vente en ligne) |
|
Pays couverts |
Chine, Japon, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Vietnam et reste de l'Asie-Pacifique |
|
Acteurs du marché couverts |
F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), QIAGEN(U.S.), Thermo Fisher Scientific Inc. (U.S.), Quest Diagnostics Incorporated, Inc. (U.S.), Siemens Healthcare GmbH (Germany), Myriad Genetics, Inc. (U.S.), Koninklijke Philips N.V. (Netherland), FUJIFILM Corporation (Japan), CANON MEDICAL SYSTEMS CORPORATION (Japan), Bio-Rad Laboratories, Inc. (U.S.), Neusoft Corporation (China), Exact Sciences Corporation(U.S.), bioMérieux SA (France), Sysmex Asia Pacific Pte Ltd (Singapore), GE HealthCare (U.S.), Medtronic(Ireland) and Agilent Technologies, Inc. (U.S.), among others. |
Market Definition of Asia-Pacific Colorectal Cancer Diagnostics Market
Colorectal cancer starts in the colon or the rectum. Depending on where they start, these cancers can also be called colon cancer or rectal cancer. Colon cancer and rectal cancer are often grouped because they have many features in common. Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Sometimes it is called colon cancer for short. The colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus.
The Asia-Pacific colorectal cancer diagnostics market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in R&D activity for launching novel services in the market. The increasing research in the field of colorectal cancer diagnosis and development is further boosting the market growth. However, difficulties in colorectal cancer screening techniques might hamper the growth of the Asia-Pacific colorectal cancer diagnostics market in the forecast period.
Asia-Pacific Colorectal Cancer Diagnostics Market Dynamics
This section deals with understanding the market drivers, advantages, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growth in the prevalence of colorectal cancer
The big intestine is where colon cancer typically first manifests itself (colon). The digestive system ends with the colon. Colon cancer can strike anyone at any age, but it often strikes older persons. Small, benign (noncancerous) cell clusters called polyps commonly grow on the interior of the colon as the first signs of the condition. Some of these polyps may eventually develop into colon cancer.
Due to various risk factors, colorectal cancer incidences have been rising in the region, becoming a significant socio-economic issue. This is expected to act as a driver in the Asia-Pacific colorectal cancer diagnostics market growth.
- Rising preference for preventive health check-ups
Preventive health check-up is preventive actions performed for the initial detection of cancer disease, and also rising preference for preventive health check-ups provide a safeguard against likely exposure to any disease in the future.
Awareness to promote screening is the most important component of cancer prevention. The check-up is comprised of the identification of cancer and examinations of risk factors to limit loss at an early stage.
Preventive cancer check-up is performed with the help of various diagnostic tests, including ultrasound, biopsy, immunohistochemistry, colorectal antibody test, and blood test (TSH, T3 and T4, TSI), among others.
Restraint
- Stringent regulatory policies
Regulation of drugs plays a significant role in healthcare. Achieving the requisite approval for legal selling medical devices or medications in such jurisdictions can entail substantial financial expenditure, which could take months or years to complete. If these constraints are not understood or taken into account, delays can seriously jeopardize the likelihood of success in a highly competitive market. The biologics such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins, among others, are of significant importance for treating various diseases. But their approval and marketing in multiple regions across the globe require a meeting of stringent regulatory standards and acceptance by various regulatory bodies.
Opportunities
- Increased demand for non-invasive testing methods
The rising demand for non-invasive testing methods in colorectal cancer diagnosis presents promising opportunities for the Asia-Pacific colorectal cancer diagnostics market. Non-invasive tests offer an attractive alternative to invasive procedures like colonoscopy, as they are more patient-friendly, less intimidating, and often do not require anaesthesia or specialized facilities. This appeals to individuals who may have been reluctant to undergo traditional screenings, leading to an expanded market and increased patient participation in regular screenings. Early detection of colorectal cancer through non-invasive tests can significantly improve patient outcomes by enabling timely treatment interventions and potentially higher survival rates. Moreover, these tests are well-suited for remote and underserved areas, as they can be easily administered in primary care settings, addressing accessibility challenges and promoting healthcare equity. With growing public health initiatives and continuous advancements in non-invasive diagnostic technologies, the Asia-Pacific colorectal cancer diagnostics market is poised to play a vital role in enhancing early detection, patient compliance, and overall management of colorectal cancer in the region.
- Strategic initiatives by market players
Increasing rates of various types of cancer disease and their severity are widely seen among people. The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by the market players. They are taking initiatives such as product launch, collaborations, mergers, acquisitions, and many more over the years and is expected to lead and create more opportunities in the market.
These strategic product launches, acquisitions, and mergers done by major companies in the colorectal cancer diagnostic market have opened up opportunities for companies in various regions. These strategies allow the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is the golden opportunity for the market players to accelerate their revenue growth in the market.
Challenge
- Late colorectal cancer diagnosis and poor prognosis
Late colorectal cancer diagnosis acts as a significant challenge in the management of the disease. When colorectal cancer is diagnosed at an advanced stage, treatment becomes more complex, and the chances of successful outcomes are reduced. Delayed diagnosis often leads to cancer spreading to nearby tissues or distant organs, making it less amenable to curative interventions. This poses challenges in developing effective treatment plans, increases the risk of complications, and may limit the available treatment options. Additionally, late-stage colorectal cancer can lead to poorer patient prognoses, reduced quality of life, and higher healthcare costs.
Recent Developments
- In August 2022, F. Hoffmann-La Roche Ltd, announced the launch of the Digital LightCycler System, Roche’s first digital polymerase chain reaction (PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods. This has helped the company to increase its Asia-Pacific presence in the market.
Asia-Pacific Colorectal Cancer Diagnostics Market Scope
Asia-Pacific colorectal cancer diagnostics market is segmented into test type, product type, cancer stages, age group, cancer type, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Test Type
- Stool Examination
- Blood Test
- Imaging Test
- Biopsy
- Others
On the basis of test type, the Asia-Pacific colorectal cancer diagnostics market is segmented into stool examination, imaging test, blood test, biopsy, and others.
Product Type
- Instruments
- Kits and Reagents
On the basis of product type, the Asia-Pacific colorectal cancer diagnostics market is segmented into instruments and kits and reagents.
Cancer Type
- Adenocarcinoma
- Colorectal Lymphoma
- Gastrointestinal Stromal Tumors
- Carcinoid Tumors
- Leiomyosarcomas
- Melanomas
- Others
On the basis of cancer type, the Asia-Pacific colorectal cancer diagnostics market is segmented into adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, leiomyosarcomas, melanomas, and others.
Cancer Stages
- Stage III
- Stage IV
- Stage II
- Stage I
- Stage 0
On the basis of stages, the Asia-Pacific colorectal cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV.
Age Group
- Geriatric
- Adults
- Pediatric
On the basis of age group, the Asia-Pacific colorectal cancer diagnostics market is segmented into geriatric, adults, and pediatric.
End User
- Hospitals
- Diagnostic Centers
- Cancer Research Centers
- Ambulatory Surgical Center
- Academic Institutes
- Others
On the basis of end user, the Asia-Pacific colorectal cancer diagnostics market is segmented into hospital, diagnostic centers, cancer research centers, ambulatory surgical centers, academic institutes, and others.
Distribution Channel
- Direct Tender
- Retail Sales
- Online Sales
On the basis of distribution channel, the Asia-Pacific colorectal cancer diagnostics market is segmented into direct tender, retail sales, and online sales.
Asia-Pacific Colorectal Cancer Diagnostics Market Regional Analysis/Insights
Asia-Pacific colorectal cancer diagnostics market is analyzed, and market size insights and trends are provided by country, product type, test type, cancer type, cancer stages, age group, end user, and distribution channel as referenced above.
The countries covered in this market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific
China is expected to dominate the Asia-Pacific colorectal cancer diagnostics market in terms of market share and revenue and will continue to flourish its dominance during the forecast period. This is due to a rising preference for preventive health check-ups.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Global brands and their challenges faced due to competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Colorectal Cancer Diagnostics Market Share Analysis
Le paysage concurrentiel du marché du diagnostic du cancer colorectal fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du diagnostic du cancer colorectal.
Français Certains des principaux acteurs opérant sur le marché du diagnostic du cancer colorectal en Asie-Pacifique sont, entre autres, F. Hoffmann-La Roche Ltd. (Suisse), Illumina, Inc. (États-Unis), QIAGEN (États-Unis), Thermo Fisher Scientific Inc. (États-Unis), Quest Diagnostics Incorporated, Inc. (États-Unis), Siemens Healthcare GmbH (Allemagne), Myriad Genetics, Inc. (États-Unis), Koninklijke Philips NV (Pays-Bas), FUJIFILM Corporation (Japon), CANON MEDICAL SYSTEMS CORPORATION (Japon), Bio-Rad Laboratories, Inc. (États-Unis), Neusoft Corporation (Chine), Exact Sciences Corporation (États-Unis), bioMérieux SA (France), Sysmex Asia Pacific Pte Ltd (Singapour), GE HealthCare (États-Unis), Medtronic (Irlande) et Agilent Technologies, Inc. (États-Unis).
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL'S MODEL
4.2 PORTER'S 5 FORCES
4.3 LIST OF DISTRIBUTORS
5 HEALTHCARE ECONOMY
5.1 HEALTHCARE EXPENDITURE
5.2 CAPITAL EXPENDITURE
5.3 CAPEX TRENDS
5.4 CAPEX ALLOCATIONS
5.5 FUNDING SOURCES
5.6 INDUSTRY BENCHMARKS
5.7 GDP RATIO IN OVERALL GDP
5.8 HEALTHCARE SYSTEM STRUCTURE
5.9 GOVERNMENT POLICIES
5.1 ECONOMIC DEVELOPMENT
6 INDUSTRY INSIGHTS
6.1 MACRO AND MICRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
7 REIMBURSEMENT SCENARIO
8 STRATEGIC ANALYSIS
8.1 JOINT VENTURES
8.2 MERGERS AND ACQUISITIONS
8.3 LICENSING AND PARTNERSHIP
8.4 TECHNOLOGY COLLABORATIONS
9 TECHNOLOGY ROADMAP
10 VALUE CHAIN ANALYSIS
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO
11.6 REGULATORY CHALLENGES AND STRATEGY
11.6.1 REGULATORY SCENARIO IN AUSTRALIA
11.6.2 REGULATORY SCENARIO IN JAPAN
11.6.3 REGULATORY SCENARIO IN CHINA
11.6.4 REGULATORY SCENARIO IN INDIA
12 MARKET OVERVIEW
12.1 DRIVERS
12.1.1 GROWING PREVALENCE OF COLORECTAL CANCER
12.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS
12.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
12.2 RESTRAINTS
12.2.1 STRINGENT REGULATORY POLICIES
12.2.2 HIGH COST FOR COLORECTAL CANCER DIAGNOSIS
12.3 OPPORTUNITIES
12.3.1 INCREASED DEMAND FOR NON-INVASIVE TESTING METHODS
12.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
12.4 CHALLENGES
12.4.1 LATE COLORECTAL CANCER DIAGNOSIS AND POOR PROGNOSIS
12.4.2 HIGH FALSE POSITIVES AND POOR SENSITIVITY OF CANCER DIAGNOSIS
13 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE
13.1 OVERVIEW
13.2 STOOL EXAMINATION
13.2.1 FECAL OCCULT BLOOD TEST (FOBT)
13.2.1.1 GUAIAC FECAL OCCULT BLOOD TEST (FOBT)
13.2.1.2 IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST (FOBT)
13.2.2 FECAL IMMUNOCHEMICAL TEST (FIT)
13.2.3 STOOL DNA TESTING
13.3 BLOOD TEST
13.3.1 COMPLETE BLOOD COUNT (CBC)
13.3.2 TUMOR MARKER TEST
13.3.2.1 CARCINOEMBRYONIC ANTIGEN (CEA)
13.3.2.2 CA19-9 BIOMARKER TEST
13.3.2.3 HER2 PROTEIN
13.3.2.4 MSI AND MMR TESTING
13.3.2.5 CA 50 MARKER TEST
13.3.2.6 KRAS, NRAS, AND BRAF GENES
13.3.2.7 OTHERS
13.3.3 LIVER ENZYME BLOOD TEST
13.4 IMAGING TEST
13.4.1 COMPUTED TOMOGRAPHY (CT) SCAN
13.4.2 MRI
13.4.3 ULTRA SOUND
13.4.3.1 ABDOMINAL ULTRASOUND
13.4.3.2 ENDORECTAL ULTRASOUND
13.4.3.3 INTRAOPERATIVE ULTRASOUND
13.4.4 POSITION EMISSION TOMOGRAPHY (PET)
13.4.5 ANGIOGRAPHY
13.4.6 COLONOSCOPY
13.4.7 SIGMOIDOSCOPY
13.4.8 OTHERS
13.5 BIOPSY
13.5.1 ENDOSCOPIC BIOPSY
13.5.2 NEEDLE BIOPSY
13.5.2.1 FINE-NEEDLE ASPIRATION
13.5.2.2 CORE NEEDLE BIOPSY
13.5.3 OTHERS
13.6 OTHERS
14 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 INSTRUMENTS
14.2.1 PATHOLOGY-BASED INSTRUMENTS
14.2.1.1 PCR INSTRUMENTS
14.2.1.2 SLIDE STAINING SYSTEMS
14.2.1.3 TISSUE PROCESSING SYSTEMS
14.2.1.4 CELL PROCESSORS
14.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS
14.2.2 IMAGING INSTRUMENTS AND ACCESSORIES
14.2.2.1 INSTRUMENTS
14.2.2.1.1 ULTRASOUND SYSTEMS
14.2.2.1.2 CT SYSTEMS
14.2.2.1.3 MRI SYSTEMS
14.2.2.1.4 OTHERS
14.2.2.2 ACCESSORIES
14.2.2.2.1 CONTRAST AGENTS
14.2.2.2.1.1 BOWEL PREPARATION KITS
14.2.2.2.1.2 CONTRAST AGENTS
14.2.2.2.2 ENDORECTAL COILS AND PROBES
14.2.2.2.3 RADIOTRACERS
14.2.2.2.4 BOWEL PREPARATION KITS
14.2.3 BIOPSY INSTRUMENTS
14.2.4 OTHERS
14.3 KITS AND REAGENTS
14.3.1 KITS
14.3.1.1 PCR KITS
14.3.1.2 DNA POLYMERASE KITS
14.3.1.3 NUCLEIC ACID ISOLATION KITS
14.3.1.4 OTHERS
14.3.2 REAGENTS
14.3.2.1 FECAL OCCULT BLOOD TEST REAGENTS
14.3.2.2 FECAL IMMUNOCHEMICAL TEST REAGENTS
14.3.2.3 STOOL DNA TEST REAGENTS
14.3.2.4 BLOOD-BASED BIOMARKER TEST REAGENTS
14.3.2.5 TISSUE-BASED BIOMARKER TEST REAGENTS
14.3.2.6 OTHERS
14.3.3 OTHER CONSUMABLES
15 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES
15.1 OVERVIEW
15.2 STAGE III
15.3 STAGE IV
15.4 STAGE II
15.5 STAGE I
15.6 STAGE 0
16 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP
16.1 OVERVIEW
16.2 GERIATRIC
16.3 ADULTS
16.4 PEDIATRIC
17 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
17.1 OVERVIEW
17.2 ADENOCARCINOMA
17.3 COLORECTAL LYMPHOMA
17.4 GASTROINTESTINAL STROMAL TUMORS
17.5 CARCINOID TUMORS
17.6 LEIOMYOSARCOMAS
17.7 MELANOMAS
17.8 OTHERS
18 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER
18.1 OVERVIEW
18.2 HOSPITALS
18.3 DIAGNOSTIC CENTERS
18.4 CANCER RESEARCH CENTERS
18.5 AMBULATORY SURGICAL CENTERS
18.6 ACADEMIC INSTITUTES
18.7 OTHERS
19 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
19.1 OVERVIEW
19.2 DIRECT TENDER
19.3 RETAIL SALES
19.4 ONLINE SALES
20 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY
20.1 ASIA-PACIFIC
20.1.1 CHINA
20.1.2 INDIA
20.1.3 JAPAN
20.1.4 SOUTH KOREA
20.1.5 THAILAND
20.1.6 SINGAPORE
20.1.7 INDONESIA
20.1.8 MALAYSIA
20.1.9 PHILIPPINES
20.1.10 AUSTRALIA
20.1.11 VIETNAM
20.1.12 REST OF ASIA-PACIFIC
21 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY
21.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
22 SWOT ANALYSIS
23 COMPANY PROFILE
23.1 KONINKLIJKE PHILIPS N.V.
23.1.1 COMPANY SNAPSHOT
23.1.2 REVENUE ANALYSIS
23.1.3 PRODUCT PORTFOLIO
23.1.4 RECENT DEVELOPMENT
23.2 F. HOFFMANN- LA ROCHE LTD
23.2.1 COMPANY SNAPSHOT
23.2.2 REVENUE ANALYSIS
23.2.3 PRODUCT PORTFOLIO
23.2.4 RECENT DEVELOPMENT
23.3 CANON MEDICAL SYSTEMS CORPORATION.
23.3.1 COMPANY SNAPSHOT
23.3.2 REVENUE ANALYSIS
23.3.3 PRODUCT PORTFOLIO
23.3.4 RECENT DEVELOPMENT
23.4 THERMO FISHER SCIENTIFIC INC.
23.4.1 COMPANY SNAPSHOT
23.4.2 REVENUE ANALYSIS
23.4.3 PRODUCT PORTFOLIO
23.4.4 RECENT DEVELOPMENT
23.5 QUEST DIAGNOSTICS INCORPORATED
23.5.1 COMPANY SNAPSHOT
23.5.2 REVENUE ANALYSIS
23.5.3 PRODUCT PORTFOLIO
23.5.4 RECENT DEVELOPMENT
23.6 AGILENT TECHNOLOGIES, INC.
23.6.1 COMPANY SNAPSHOT
23.6.2 REVENUE ANALYSIS
23.6.3 PRODUCT PORTFOLIO
23.6.4 RECENT DEVELOPMENT
23.7 BIOMÉRIEUX SA
23.7.1 COMPANY SNAPSHOT
23.7.2 REVENUE ANALYSIS
23.7.3 PRODUCT PORTFOLIO
23.7.4 RECENT DEVELOPMENT
23.8 BIO-RAD LABORATORIES, INC.
23.8.1 COMPANY SNAPSHOT
23.8.2 REVENUE ANALYSIS
23.8.3 PRODUCT PORTFOLIO
23.8.4 RECENT DEVELOPMENT
23.9 EXACT SCIENCES CORPORATION
23.9.1 COMPANY SNAPSHOT
23.9.2 REVENUE ANALYSIS
23.9.3 PRODUCT PORTFOLIO
23.9.4 RECENT DEVELOPMENT
23.1 FUJIFILM CORPORATION
23.10.1 COMPANY SNAPSHOT
23.10.2 REVENUE ANALYSIS
23.10.3 PRODUCT PORTFOLIO
23.10.4 RECENT DEVELOPMENT
23.11 GE HEALTHCARE.
23.11.1 COMPANY SNAPSHOT
23.11.2 REVENUE ANALYSIS
23.11.3 PRODUCT PORTFOLIO
23.11.4 RECENT DEVELOPMENT
23.12 ILLUMINA, INC.
23.12.1 COMPANY SNAPSHOT
23.12.2 REVENUE ANALYSIS
23.12.3 PRODUCT PORTFOLIO
23.12.4 RECENT DEVELOPMENT
23.13 MYRIAD GENETICS, INC.
23.13.1 COMPANY SNAPSHOT
23.13.2 REVENUE ANALYSIS
23.13.3 PRODUCT PORTFOLIO
23.13.4 RECENT DEVELOPMENT
23.14 MEDTRONIC
23.14.1 COMPANY SNAPSHOT
23.14.2 REVENUE ANALYSIS
23.14.3 PRODUCT PORTFOLIO
23.14.4 RECENT DEVELOPMENT
23.15 NEUSOFT CORPORATION
23.15.1 COMPANY SNAPSHOT
23.15.2 REVENUE ANALYSIS
23.15.3 PRODUCT PORTFOLIO
23.15.4 RECENT DEVELOPMENT
23.16 QIAGEN
23.16.1 COMPANY SNAPSHOT
23.16.2 REVENUE ANALYSIS
23.16.3 PRODUCT PORTFOLIO
23.16.4 RECENT DEVELOPMENT
23.17 SIEMENS HEALTHCARE GMBH
23.17.1 COMPANY SNAPSHOT
23.17.2 REVENUE ANALYSIS
23.17.3 PRODUCT PORTFOLIO
23.17.4 RECENT DEVELOPMENT
23.18 SYSMEX ASIA PACIFIC PTE LTD
23.18.1 COMPANY SNAPSHOT
23.18.2 PRODUCT PORTFOLIO
23.18.3 RECENT DEVELOPMENT
24 QUESTIONNAIRE
25 RELATED REPORTS
Liste des tableaux
TABLE 1 COST OF DIAGNOSTIC TEST FOR COLORECTAL CANCER IN INDIA
TABLE 2 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC KITS AND REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 51 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 52 CHINA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 53 CHINA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 54 CHINA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 55 CHINA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 56 CHINA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 57 CHINA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 58 CHINA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 59 CHINA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 60 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 61 CHINA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 CHINA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 63 CHINA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 CHINA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 65 CHINA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 66 CHINA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 67 CHINA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 68 CHINA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 69 CHINA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 71 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 72 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 73 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 74 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 75 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 76 INDIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 INDIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 78 INDIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 INDIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 80 INDIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 81 INDIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 82 INDIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 83 INDIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 85 INDIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 INDIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 87 INDIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 88 INDIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 89 INDIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 90 INDIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 INDIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 92 INDIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 INDIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 94 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 95 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 96 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 97 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 99 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 JAPAN STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 101 JAPAN FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 102 JAPAN BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 103 JAPAN TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 104 JAPAN IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 105 JAPAN ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 106 JAPAN BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 JAPAN NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 108 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 109 JAPAN INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 110 JAPAN PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 111 JAPAN IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 JAPAN INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 113 JAPAN ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 JAPAN CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 115 JAPAN KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 116 JAPAN KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 117 JAPAN REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 118 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 119 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 120 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 121 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 122 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 123 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 124 SOUTH KOREA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 125 SOUTH KOREA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 SOUTH KOREA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 127 SOUTH KOREA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 SOUTH KOREA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 129 SOUTH KOREA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 130 SOUTH KOREA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 131 SOUTH KOREA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 132 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 SOUTH KOREA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 134 SOUTH KOREA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 135 SOUTH KOREA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 136 SOUTH KOREA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 137 SOUTH KOREA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 138 SOUTH KOREA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 139 SOUTH KOREA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 SOUTH KOREA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 141 SOUTH KOREA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 143 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 144 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 145 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 146 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 147 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 148 THAILAND STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 THAILAND FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 150 THAILAND BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 151 THAILAND TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 152 THAILAND IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 153 THAILAND ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 154 THAILAND BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 155 THAILAND NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 157 THAILAND INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 THAILAND PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 159 THAILAND IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 160 THAILAND INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 161 THAILAND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 162 THAILAND CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 163 THAILAND KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 164 THAILAND KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 THAILAND REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 166 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 167 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 168 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 169 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 170 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 171 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 SINGAPORE STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 173 SINGAPORE FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 174 SINGAPORE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 175 SINGAPORE TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 176 SINGAPORE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 SINGAPORE ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 178 SINGAPORE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 179 SINGAPORE NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 180 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 181 SINGAPORE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 182 SINGAPORE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 183 SINGAPORE IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 SINGAPORE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 185 SINGAPORE ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 SINGAPORE CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 187 SINGAPORE KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 188 SINGAPORE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 189 SINGAPORE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 190 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 191 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 192 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 194 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 195 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 196 INDONESIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 197 INDONESIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 INDONESIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 199 INDONESIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 INDONESIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 201 INDONESIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 202 INDONESIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 203 INDONESIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 204 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 INDONESIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 206 INDONESIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 INDONESIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 208 INDONESIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 209 INDONESIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 210 INDONESIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 211 INDONESIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 212 INDONESIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 213 INDONESIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 214 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 215 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 216 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 217 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 219 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 220 MALAYSIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 MALAYSIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 222 MALAYSIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 223 MALAYSIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 224 MALAYSIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 225 MALAYSIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 226 MALAYSIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 227 MALAYSIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 228 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 229 MALAYSIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 230 MALAYSIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 231 MALAYSIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 232 MALAYSIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 233 MALAYSIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 234 MALAYSIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 MALAYSIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 236 MALAYSIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 MALAYSIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 238 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 239 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 240 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 241 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 242 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 243 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 244 PHILIPPINES STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 245 PHILIPPINES FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 246 PHILIPPINES BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 247 PHILIPPINES TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 248 PHILIPPINES IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 249 PHILIPPINES ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 250 PHILIPPINES BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 PHILIPPINES NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 252 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 PHILIPPINES INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 254 PHILIPPINES PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 255 PHILIPPINES IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 256 PHILIPPINES INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 257 PHILIPPINES ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 258 PHILIPPINES CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 259 PHILIPPINES KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 260 PHILIPPINES KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 261 PHILIPPINES REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 262 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 263 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 264 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 265 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 266 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 267 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 268 AUSTRALIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 269 AUSTRALIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 270 AUSTRALIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 271 AUSTRALIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 272 AUSTRALIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 273 AUSTRALIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 274 AUSTRALIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 275 AUSTRALIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 276 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 277 AUSTRALIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 278 AUSTRALIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 279 AUSTRALIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 280 AUSTRALIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 281 AUSTRALIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 282 AUSTRALIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 283 AUSTRALIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 284 AUSTRALIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 285 AUSTRALIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 286 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 287 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 288 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 289 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 290 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 291 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 292 VIETNAM STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 293 VIETNAM FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 294 VIETNAM BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 295 VIETNAM TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 296 VIETNAM IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 297 VIETNAM ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 298 VIETNAM BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 299 VIETNAM NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 300 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 301 VIETNAM INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 302 VIETNAM PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 303 VIETNAM IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 304 VIETNAM INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 305 VIETNAM ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 306 VIETNAM CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 307 VIETNAM KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 308 VIETNAM KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 309 VIETNAM REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 310 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 311 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 312 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 313 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 314 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 315 REST OF ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
Liste des figures
FIGURE 1 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: MARKET END-USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT COLORECTAL CANCER IS EXPECTED TO DRIVE THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE STOOL EXAMINATION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET
FIGURE 14 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022
FIGURE 15 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD THOUSAND)
FIGURE 16 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 17 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022
FIGURE 19 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND)
FIGURE 20 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 21 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022
FIGURE 23 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD THOUSAND)
FIGURE 24 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030)
FIGURE 25 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022
FIGURE 27 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD THOUSAND)
FIGURE 28 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030)
FIGURE 29 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022
FIGURE 31 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD THOUSAND)
FIGURE 32 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030)
FIGURE 33 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2022
FIGURE 35 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 36 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 39 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 40 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 41 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 43 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 44 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE (2023-2030)
FIGURE 47 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
